Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LUCD
#3531
Lucid Diagnostics Inc. Common Stock
1.3
5
USD
+5.47%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+5.47%
Monthly Change
-3.57%
6 month change
+12.50%
Year Change
+11.57%
Previous Close
1.2
8
Open
1.3
5
Bid
Ask
Low
1.3
5
High
1.3
5
Volume
23
Markets
US Stock Market
Healthcare
LUCD
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.43 M
43.39 M
48.24 M
90.75 M
176.95 M
—
Valuation ratios
Enterprise value
147.36 M
37.84 M
82.04 M
127.62 M
238.26 M
783.92 M
Price to earnings ratio
—
-0.9
-1.1
-0.78
-1.92
-5.48
Price to sales ratio
—
133.37
23.9
9.52
23.61
75.89
Price to cash flow ratio
—
-1.69
-1.77
-0.94
-2.39
-7.62
Price to book ratio
—
2.18
-2.77
-0.84
-2.56
-3.71
Enterprise value to EBITDA ratio
-5.38
-0.25
-1.45
-2.37
-8.37
-18.12
Profitability ratios
Return on assets %
-0.48
-1.73
-1.93
-1.48
-1.43
-1.53
Return on equity %
-0.51
-2.44
22.79
-8.45
-5.3
2.55
Return on invested capital %
-4 002.77
-2 672.42
-877.18
-662.87
-744.95
-621.61
Gross margin %
-17
100
100
100
-41.73
—
Operating margin %
-5 483.8
-14.9 K
-1 996.79
-1 059.64
-1 054.82
—
EBITDA margin %
-5 483
-40.91 K
-1 893.86
-1 032.79
-539.31
—
Net margin %
-5 615.6
-14.9 K
-2 169.11
-1 047.61
-1 232.68
—
Liquidity ratios
Quick ratio
—
—
0.74
1.05
1.3
5.05
Current ratio
22.01
2.89
0.75
1.07
1.31
5.12
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.08
0.15
0.13
0.08
Solvency ratios
Debt to assets ratio
—
—
0.56
0.69
0.64
2.88
Debt to equity ratio
—
—
-6.6
3.94
2.36
0.25
Long term debt to total assets ratio
—
—
0.51
0.61
0.59
2.67
Long term debt to total equity ratio
—
—
-6.04
3.45
2.19
0.18
Per share metrics
Operating cash flow per share
—
-0.82
-0.79
-0.87
-0.46
-0.51
EBIT per share
—
-4.32
-1.16
-0.91
-0.49
-0.47
EBITDA per share
—
-4.26
-1.1
-0.89
-0.25
-0.46
Total debt per share
—
—
0.37
0.42
0.25
1.27
Cash per share
—
0.62
0.45
0.44
0.34
1.46
Net current asset value per share
—
0.67
0.53
0.5
0.37
1.57
Tangible book value per share
—
0.54
-0.54
-0.99
-0.43
-2.05
Working capital per share
—
0.44
-0.18
0.03
0.09
0.22
Book value per share
—
0.64
-0.5
-0.97
-0.43
-2.03
News
Lucid Diagnostics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:LUCD) 2026-03-27
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript
Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
Lucid Diagnostics earnings beat, revenue fell short of estimates
Orthofix (OFIX) Q4 Earnings and Revenues Lag Estimates
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
PAVmed raises $45 million, restructures capital to eliminate convertible debt